MedTrace Logo

Investigate eNAMPT in Multiple Myeloma Biology and Establish Its Role in Disease Progression

NCT04137523 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 26

Last updated 2024-12-11

No results posted yet for this study

Summary

Based on our previous observations, here the investigator plans to further investigate eNAMPT in MM biology and to establish its role in disease progression where EMT acquisition represents an hallmark of cancers. Results deriving from proposal would hopefully identify novel biological vulnerabilities of such malignancy and an innovative biomarker for disease progression monitoring as well.

Conditions

Sponsors & Collaborators

  • University of Turin, Italy

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-08-12
Primary Completion
2019-08-12
Completion
2024-12-10

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04137523 on ClinicalTrials.gov